Archives: Speakers

My professional history is directly related to my 20+ years’ experience managing operations in healthcare sector across multiple locations, including Europe, US and Canada. What makes me stand-out is my record of optimising current processes to deliver quality services, establishing and growing businesses, and increasing staff performance and satisfaction. I am meticulous, creative, and focused professional with proven talent to foster productive relationships with top businesses / clients across all pharma segments. I excel at managing projects in all clinical phases, overseeing large budgets, as well as directing multidisciplinary global teams to exceed company KPIs while keeping the people development & care as main driver.

Stacy Lee is a Global Clinical Project Manager at Novotech. With a background in Human Biology and over 13 years of experience in global clinical operations, she has led multi-country oncology and radiopharmaceutical programs from early development through pivotal stages. Recognized as a subject matter expert in radiopharmaceutical clinical trials, Stacy specializes in translating complex science into operational strategy, proactive risk assessment, and mitigation planning to ensure trial integrity and delivery excellence. She is passionate about advancing targeted therapies and strengthening global partnerships to accelerate clinical development worldwide.

Dr. Hyojin Park earned his Bachelor’s degree in Psychology from Indiana University Bloomington and his Doctorate in Medical Sciences from Yonsei University. He is currently with GlobalData, where he leads consulting and data solution initiatives for the pharmaceutical and biotechnology sectors, supporting both industry and government clients. Prior to this, he served as a Senior Consultant at Clarivate, working on strategic projects across global life sciences markets. Since 2021, Dr. Park has presented data-driven analyses and market outlooks on the pharmaceutical and biotech industries at major conferences and government-sponsored events.

Guido Wuerth joined Affibody AB in September 2021, where he serves as Head of Corporate Development, Radiopharma. In this role, he oversees asset management across the company’s radiopharmaceutical portfolio.

He joined Affibody from MorphoSys, where he led Clinical Development and served as Global Program Head for several immunology programs. During his tenure, he played a key role in the U.S. approval of tafasitamab (MONJUVI®) for the treatment of Non-Hodgkin Lymphoma and contributed to the successful execution of multi-million Euro out-licensing agreements.

Prior to 2017, he managed Global Clinical Operations at Sandoz, leading a team of approximately 100 professionals. Earlier at Sandoz, he served as Global Program Medical Director for the clinical development of the etanercept biosimilar Erelzi®, gaining extensive experience in regulatory interactions with health authorities.

Previously, Guido held global roles in Clinical Development and Clinical Operations at Baxter BioSciences, Antisense Pharma, and Schwarz Pharma (now part of UCB). He is a board-certified urologist and holds a medical degree from the University of Cologne, Germany.

Todd is responsible for Celent in India, Middle East and Africa (IMEA) and Asia Pacific (AP) regions and has over 30 years experience in technology advisory and consultancy.

He has conducted business in over 50 countries across five continents and previously held Vice President, Partner and General Management level positions with NASDAQ and NYSE listed global technology research and advisory firms Gartner, Meta Group and Forrester in both EMEA and Asia Pacific where he was also a valued member of global Senior Leadership Teams.

His expertise is established in his knowledge of the business application of technology across a wide range of industry verticals with a core focus on banking, financial services and insurance.

Todd helps enterprises and solution providers alike to leverage their investments in gaining strategic and operational advantage to deliver high quality, consequential outcomes with optimal returns on investment.

An open and forward thinker, Todd thrives in multi-cultural environments and is valued by clients for his commercial focus and innovative approach.

Andy Ingram-Tedd is a dynamic leader with over 15 years of technology experience in consumer packaged goods, operations, project management, and product development. At Ocado Intelligent Automation (OIA), part of Ocado Group, he leads a team dedicated to designing and integrating cutting-edge technology into OIA solutions. He is directly involved in developing the Ocado Storage and Retrieval System (OSRS) and setting strategies for efficient warehouse operations. Since joining Ocado Group in 2002, he has significantly contributed to its operational and project management successes and holds over 50 patents. His leadership in complex design challenges consistently drive innovation and operational excellence.